Correlation of thrombospondin-1 and transforming growth factor-β expression with malignancy of glioma

Neuropathology

Volumn 20, Issue 3, 2000, Pages 161-169

  Kawataki, Tomoyuki ^a   Naganuma, Hirofumi ^a   Sasaki, Atsushi ^a   Yoshikawa, Hideji ^a   Tasaka, Kachio ^a   Nukui, Hideaki ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Athrombospondin 1; Malignant glioma; Transforming growth factor

Indexed keywords

MATRIX PROTEIN; MESSENGER RNA; THROMBOSPONDIN 1; THROMBOSPONDIN 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE;

ASTROCYTOMA; DIAGNOSIS, DIFFERENTIAL; GLIOBLASTOMA; GLIOMA; HUMANS; RNA, MESSENGER; THROMBOSPONDIN 1; THROMBOSPONDINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034426392     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00327.x     Document Type: Article

References (55)

1. Regulation of tumor growth and metastasis by thrombospondin 1
2. The role of thrombospondin-1 in tumor progression and angiogenesis
3. Thrombospondins
4. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system
5. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-β
6. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism
7. Regulation of transforming growth factor-β activation by discrete sequences of thrombospondin 1
8. Thrombospondin-1 is a major activator of TGF-β1 in vivo
9. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors
10. A new type of transforming growth factor-β, TGF-β3
11. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
12. Transforming growth factor-βI cDNA cloning and sequence analysis
13. Improved bioassay for the detection of transforming growth factor-β1 and -β2 in malignant gliomas
14. Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes
15. Secretion of transforming growth factor-β1 and -β2 by malignant glioma cells
16. Resistance to growth inhibition by transforming growth factor-β in malignant glioma cells with functional receptors
17. Tumor suppressor genes in the TGF-β signaling pathway?
18. Inhibition of cytokine production by cyclosporin A and transforming growth factorβ
19. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
20. Inhibition of tumor necrosis factor-α and -β secretion by lymphokine activated killer cells by transforming growth factor-β
21. Effects of transforming growth factor-β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
22. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
23. Transforming growth factor-β (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNA in normal human dermal fibroblasts
24. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
25. Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane
26. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1
27. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells
28. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia
29. Human brain glial cells synthesize thrombospondin
30. Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease
31. Expression and function of thrombospondin-1 in myelinating glial cells of the central nervous system
32. Distribution of transforming growth factor-β1 in human astrocytomas
33. Enhanced expression of transforming growth factor-β and its typed and type-II receptors in human glioblastoma
34. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor-β1
35. Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-β antisense gene
36. Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion
37. Expression of thrombospondin (TSP1) and its receptors (CD36 and CDS1) in normal, hyperplastic, and neoplastic human breast
38. Involvement of thrombospondin in the adherence of human breast-adenocarcinoma cells: A possible role in the metastatic process
39. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
40. Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells
41. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum-and anchorage-independent NIH 3T3 cells
42. Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma
43. Thrombospondin, a potentiator of tumor cell metastasis
44. Tumor angiogenesis: The role of oncogenes and tumor suppressor gene
45. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
46. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
47. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain
48. Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor
49. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
50. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells
51. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
52. Fibroblast growth factor messenger ribonucleic acid expression in a human astrocytoma cell line: Regulation by serum and cell density
53. Fibroblast growth factor release by bovine endothelial cells and human astrocytoma cells in culture is density dependent
54. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo